Cannara Biotech Inc. reported earnings results for the second quarter and six months ended February 28, 2023. For the second quarter, the company reported sales was CAD 0.896053 million compared to CAD 0.827187 million a year ago. Revenue was CAD 13.04 million compared to CAD 7.42 million a year ago. Net loss was CAD 0.618055 million compared to CAD 1.15 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.
For the six months, sales was CAD 1.76 million compared to CAD 1.73 million a year ago. Revenue was CAD 23.35 million compared to CAD 13.99 million a year ago. Net loss was CAD 0.615104 million compared to CAD 1.68 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.02 a year ago.